Polycystic Kidney, Autosomal Dominant
"Polycystic Kidney, Autosomal Dominant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.
| Descriptor ID |
D016891
|
| MeSH Number(s) |
C12.777.419.403.875.500 C13.351.968.419.403.875.500 C16.131.077.717.500 C16.320.798.500
|
| Concept/Terms |
Polycystic Kidney, Autosomal Dominant- Polycystic Kidney, Autosomal Dominant
- Kidney, Polycystic, Autosomal Dominant
- Polycystic Kidney Disease, Adult
- Adult Polycystic Kidney Disease
- Polycystic Kidney Disease, Autosomal Dominant
- Autosomal Dominant Polycystic Kidney
- ADPKD
Polycystic Kidney, Type 2 Autosomal Dominant Disease- Polycystic Kidney, Type 2 Autosomal Dominant Disease
- Polycystic Kidney Disease, Adult, Type II
- Polycystic Kidney Disease, Type 2
- Polycystic Kidney Disease, Adult Type 2
- Adult Polycystic Kidney Disease Type 2
- Polycystic Kidney Disease 2
|
Below are MeSH descriptors whose meaning is more general than "Polycystic Kidney, Autosomal Dominant".
- Diseases [C]
- Male Urogenital Diseases [C12]
- Urologic Diseases [C12.777]
- Kidney Diseases [C12.777.419]
- Kidney Diseases, Cystic [C12.777.419.403]
- Polycystic Kidney Diseases [C12.777.419.403.875]
- Polycystic Kidney, Autosomal Dominant [C12.777.419.403.875.500]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Urologic Diseases [C13.351.968]
- Kidney Diseases [C13.351.968.419]
- Kidney Diseases, Cystic [C13.351.968.419.403]
- Polycystic Kidney Diseases [C13.351.968.419.403.875]
- Polycystic Kidney, Autosomal Dominant [C13.351.968.419.403.875.500]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Congenital Abnormalities [C16.131]
- Abnormalities, Multiple [C16.131.077]
- Polycystic Kidney Diseases [C16.131.077.717]
- Polycystic Kidney, Autosomal Dominant [C16.131.077.717.500]
- Genetic Diseases, Inborn [C16.320]
- Polycystic Kidney Diseases [C16.320.798]
- Polycystic Kidney, Autosomal Dominant [C16.320.798.500]
Below are MeSH descriptors whose meaning is more specific than "Polycystic Kidney, Autosomal Dominant".
This graph shows the total number of publications written about "Polycystic Kidney, Autosomal Dominant" by people in this website by year, and whether "Polycystic Kidney, Autosomal Dominant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 6 | 1 | 7 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 5 | 0 | 5 |
| 2007 | 2 | 0 | 2 |
| 2008 | 6 | 0 | 6 |
| 2009 | 5 | 0 | 5 |
| 2010 | 4 | 0 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 4 | 0 | 4 |
| 2013 | 6 | 0 | 6 |
| 2014 | 8 | 0 | 8 |
| 2015 | 8 | 0 | 8 |
| 2016 | 13 | 0 | 13 |
| 2017 | 17 | 0 | 17 |
| 2018 | 7 | 0 | 7 |
| 2019 | 6 | 0 | 6 |
| 2020 | 9 | 1 | 10 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polycystic Kidney, Autosomal Dominant" by people in Profiles.
-
ALTERATIONS IN HISTIDINE METABOLISM IS A FEATURE OF EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). Trans Am Clin Climatol Assoc. 2024; 134:47-65.
-
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY. Kidney360. 2024 Apr 01; 5(4):499-500.
-
Pregnancy in Autosomal Dominant Polycystic Kidney Disease. Adv Kidney Dis Health. 2023 09; 30(5):454-460.
-
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation. Kidney Int. 2023 08; 104(2):334-342.
-
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial. Am J Kidney Dis. 2023 05; 81(5):517-527.e1.
-
Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States. Clin J Am Soc Nephrol. 2022 07; 17(7):976-985.
-
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2022 03; 17(3):374-384.
-
Polycystic Kidney Disease in the Real World. Kidney360. 2021 12 30; 2(12):1882-1883.
-
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review. PLoS One. 2021; 16(5):e0252479.
-
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2020 12 31; 16(1):48-58.